Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies

Clicks: 240
ID: 271840
2020
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
The beginning of 2020 has seen the emergence of COVID-19 outbreak caused by a novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). There is an imminent need to better understand this new virus and to develop ways to control its spread. In this study, we sought to gain ins …
Reference Key
sf2020virusespreliminary Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Ahmed SF;Quadeer AA;McKay MR;;
Journal Viruses
Year 2020
DOI
DOI not found
URL
https://www.ncbi.nlm.nih.gov/sites/entrez/32106567
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE covid-19 sars-cov-2 humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't genome Viral Phylogeny pneumonia epitopes t-lymphocyte / immunology protein structure tertiary sars virus / genetics viral vaccines / immunology* betacoronavirus / immunology* spike glycoprotein viral / prevention & control phosphoproteins pmid:32106567 pmc7150947 doi:10.3390/v12030254 syed faraz ahmed ahmed a quadeer matthew r mckay betacoronavirus / genetics covid-19 vaccines coronavirus infections / prevention & control coronavirus nucleocapsid proteins epitope mapping b-lymphocyte / genetics b-lymphocyte / immunology t-lymphocyte / genetics nucleocapsid proteins / genetics nucleocapsid proteins / immunology* sars virus / immunology coronavirus / genetics coronavirus / immunology*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.